Issue Area - Medicaid Pharmaceutical Plan Resources
Health Care Budgeting: Tools & Techniques for State Budget Officers, May 2005
Health care is the second-largest and fastest growing item in state budgets. State health care spending includes Medicaid, state employees health benefits program, public mental health services, and public health. Many states have reached the point of cutting eligibility or benefits in order to balance their revenue deficient budgets. In a rapidly changing environment, it is essential that state budget officers keep abreast of the innovations in developing health budgets and ensure that all the many options have been considered.
This webcast captures the executive fellowship held at the College of William & Mary in May 2005.
The Impact on States of the Medicare Drug Benefit: Information for State Administrators, 2005
As administrators work to integrate Medicaid and state prescription assistance programs with the new drug benefit established by Part D of the Medicare Modernization Act, there will be significant savings opportunities as well as significant costs. The decisions states make must not only reflect budget considerations, but must also recognize the lead role that states have in providing a safety net to the poorest, frailest, and most vulnerable of our citizens. This issue brief identifies key decision points and factors that must be taken into consideration as states prepare for the January 1st, 2006 implementation of the new Medicare drug benefit.
The Impact on States of the Medicare Drug Benefit: Information for State Legislators, 2005
The new drug benefit established by Part D of the Medicare Modernization Act assures that all older and disabled persons have access to affordable prescription drug coverage and will subsidize many low-income persons who previously had no access to drug benefits through Medicaid or state pharmaceutical assistance programs. States have numerous policy decisions to
make in implementing the Part D drug benefit, including several options to enhance the Part D program. These decisions must be made quickly in order to be ready for the January 1st, 2006 implementation date. As the safety net provider for many vulnerable individuals, the state's choices on these matters are important to the future well-being of the elderly and disabled.
Medicaid 101 - Overview of Policies, Expenditures, Current Trends, and Initiatives
Medicaid 101 for State Legislators is designed to help legislators and their staffs:
- Understand the history and mission of Medicaid
- The drivers behind Medicaid budget growth (e.g., aged, blind, disabled eligibility expansions)
- The part that drugs play in the budget.
The presentation explains how barriers to care that delay effective treatment can add to long-term costs and reduce quality; examines a range of alternatives (along with their pros and cons) for managing drug expenditures; highlights extensive state-specific data on the Medicaid population.
The Medicare Drug Benefit: Impact on States, and Cost Containment
This presentation outlines key MMA issues for Medicaid, State Pharmaceutical Assistance Programs (SPAPs), other state agencies, and state employee retiree benefit plans. It also reviews Medicaid cost-containment options being considered in the states related to eligibility, benefits, unit cost, utilization, managed care, revenue enhancement and cost avoidance, and administrative
efficiencies.
Pharmaceutical Benefits Under State Medical Assistance Programs, 2005/2006 and Previous Editions
The 2005-2006 edition of Pharmaceutical Benefits Under State Medical Assistance Programs marks the 40th year that NPC has compiled and published one of the largest sources of information on pharmacy programs within the State Medical Assistance Programs (Title XIX) and expanded pharmacy programs for the elderly and disabled. Over the years, this collection of statistical data has become a standard reference in government offices, research libraries, consultancies, and numerous businesses. It incorporates information on each State pharmacy program from an annual NPC Survey of State Medicaid program administrators and pharmacy consultants, statistics from the Centers for Medicare and Medicaid Services (CMS), and information from other Federal agencies and organizations.
State Medicaid Program Issues: Preferred Drug Lists, 2003
This issue brief identifies issues, requirements and considerations relating to preferred drug lists (PDLs). Developed for state audiences, the brief addresses policy, operational and procedural issues; federal provisions for patient protection; specific case studies; provisions of the Florida Medicaid patient suit settlement agreement; evaluation methodologies; and principles
to consider.
State Medicaid Resource Kit: Maintaining Quality and Patient Access to Innovative Pharmaceuticals in Challenging Economic Times, 2006
This resource kit, modeled on NCSL's "Managing Medicaid Costs: A Legislator's Toolkit," is designed to help states better identify the needs of their populations and to develop patient-focused cost management interventions while maintaining quality care. Sixteen specific strategies are addressed, providing the pros and cons, states' experiences, design and policy issues, and Federal and State involvement/constraints.
|
